Course: Experts in Conversation: Highlights from CTAD 2024 – 2 with Charlotte Teunissen and Suzanne Schindler | Journey to a New Era for Alzheimer’s Disease
CME Credits: 0.25
Released: 2024-04-03
2024 brought pivotal advances in neurodegenerative biomarkers for early Alzheimer’s detection, insights into amyloid-targeted therapies and patient selection, and new strategies for ARIA risk assessment and management. Revisit 2024 Conference Highlights for Alzheimer’s Disease. Watch Experts in Conversation: Highlights from CTAD 2024 – 2, featuring Charlotte Teunissen (The Netherlands) and Suzanne Schindler (USA). This program is part of the larger initiative, Journey to a New Era for Alzheimer’s Disease. Register for free to access news articles, video highlights, accredited expert discussions, concise research summaries, podcasts, and interactive quizzes to test your knowledge: https://new-era-alzheimers-disease.ime.springerhealthcare.com/.
After participating in this program, you will be able to:
View Full Course